ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

TBIO Telesis Bio Inc

4.10
0.435 (11.87%)
May 31 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 68,085
Bid Price 4.10
Ask Price 4.38
News -
Day High 4.3697

Low
3.33

52 Week Range

High
39.24

Day Low 3.65
Company Name Stock Ticker Symbol Market Type
Telesis Bio Inc TBIO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.435 11.87% 4.10 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.65 3.65 4.3697 4.08 3.665
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,437 68,085 $ 3.98 $ 271,026 - 3.33 - 39.24
Last Trade Time Type Quantity Stock Price Currency
18:40:09 1 $ 4.10 USD

Telesis Bio Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
128.33M 29.98M - 27.51M -49.02M -1.64 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Telesis Bio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TBIO Message Board. Create One! See More Posts on TBIO Message Board See More Message Board Posts

Historical TBIO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.654.36973.333.5719,6170.4512.33%
1 Month6.11287.28823.335.47163,497-2.01-32.93%
3 Months9.376210.61823.336.56108,081-5.28-56.27%
6 Months7.635615.4623.3310.37431,068-3.54-46.30%
1 Year31.3239.243.3310.90287,105-27.22-86.91%
3 Years334.08683.733.33426.07625,564-329.98-98.77%
5 Years194.76683.733.33359.54743,195-190.66-97.89%

Telesis Bio Description

Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of solutions that prevent the building of virtually error-free DNA and mRNA at a useable scale. Its on-market and planned solutions include BioXp 3250 system, BioXp 9600 system, BioXp DBC, BioXp portal, BioXp De Novo kits, BioXp Select kits, BioXp Next Generation Sequencing kits, BioXp DBC kits, Benchtop reagents and Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis (EDS). BioXp 3250 system is a push-button, walkaway, end-to-end automated workstation that offers endpoint-ready synthetic DNA in as few as 8 hours and mRNA in less than 24 hours. BioXp DBC is engaged in delivering on-demand enzymatic DNA synthesis with design-to-endpoint-ready synthetic RNA in as few as 24 hours.